Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 106

1.

Inductive/effector mechanisms for humoral immunity at mucosal sites.

Wright PF.

Am J Reprod Immunol. 2011 Mar;65(3):248-52. doi: 10.1111/j.1600-0897.2010.00954.x. Epub 2011 Jan 12. Review.

PMID:
21223423
3.

Mucosal antibody responses to HIV.

Moldoveanu Z, Mestecky J.

Methods Mol Biol. 2009;485:333-45. doi: 10.1007/978-1-59745-170-3_22.

PMID:
19020835
4.

Humoral immune responses to HIV in the mucosal secretions and sera of HIV-infected women.

Mestecky J, Wei Q, Alexander R, Raska M, Novak J, Moldoveanu Z.

Am J Reprod Immunol. 2014 Jun;71(6):600-7. doi: 10.1111/aji.12203. Epub 2014 Feb 5. Review.

5.

Humoral immune responses to the human immunodeficiency virus type-1 (HIV-1) in the genital tract compared to other mucosal sites.

Mestecky J.

J Reprod Immunol. 2006 Dec;72(1-2):1-17. Review. Erratum in: J Reprod Immunol. 2007 Feb;73(1):85. Corrected and republished in: J Reprod Immunol. 2007 Feb;73(1):86-97.

PMID:
17095369
6.

The role of mucosal immunity in prevention of HIV transmission.

Kozlowski PA, Neutra MR.

Curr Mol Med. 2003 May;3(3):217-28. Review.

PMID:
12699359
7.

Protecting the initial site of viral entry: an alternative HIV vaccine target.

Lopalco L, Bomsel M.

Expert Rev Vaccines. 2011 Sep;10(9):1253-6. doi: 10.1586/erv.11.98. No abstract available.

PMID:
21919613
8.

Meeting of the minds on mucosal transmission.

von Bubnoff A.

IAVI Rep. 2010 May-Jun;14(3):10-1, 14. No abstract available.

9.

Oral mucosal immunity and HIV infection: current status.

Challacombe SJ, Sweet SP.

Oral Dis. 2002;8 Suppl 2:55-62. Review.

PMID:
12164661
10.
11.

Induction of optimal immune responses against human immunodeficiency virus at mucosal portals of entry.

Vajdy M.

Curr Drug Targets Immune Endocr Metabol Disord. 2003 Sep;3(3):222-33. Review.

PMID:
12871029
12.

Functional CD8+ CTLs in mucosal sites and HIV infection: moving forward toward a mucosal AIDS vaccine.

Belyakov IM, Ahlers JD.

Trends Immunol. 2008 Nov;29(11):574-85. doi: 10.1016/j.it.2008.07.010. Review.

PMID:
18838298
13.

Mucosal innate immunity as a determinant of HIV susceptibility.

Iqbal SM, Kaul R.

Am J Reprod Immunol. 2008 Jan;59(1):44-54. Review.

PMID:
18154595
14.

An HIV-based lentiviral vector as HIV vaccine candidate: Immunogenic characterization.

Lemiale F, Asefa B, Ye D, Chen C, Korokhov N, Humeau L.

Vaccine. 2010 Feb 23;28(8):1952-61. doi: 10.1016/j.vaccine.2009.10.089.

PMID:
20188251
15.

The immune response to HIV: implications for vaccine development.

Bolognesi DP.

Semin Immunol. 1993 Jun;5(3):203-14. Review.

PMID:
8347841
16.

Immunologic uniqueness of the genital tract: challenge for vaccine development.

Mestecky J, Moldoveanu Z, Russell MW.

Am J Reprod Immunol. 2005 May;53(5):208-14. Review.

PMID:
15833098
18.

Human immunodeficiency virus type 1 and mucosal humoral defense.

Janoff EN, Scamurra RW, Sanneman TC, Eidman K, Thurn JR.

J Infect Dis. 1999 May;179 Suppl 3:S475-9. Review.

PMID:
10099123
19.

The mucosal immune system: from control of inflammation to protection against infections.

Kaiserlian D, Cerf-Bensussan N, Hosmalin A.

J Leukoc Biol. 2005 Aug;78(2):311-8. Epub 2005 May 13.

PMID:
15894590
20.

Methods for evaluation of humoral immune responses in human genital tract secretions.

Mestecky J, Alexander RC, Wei Q, Moldoveanu Z.

Am J Reprod Immunol. 2011 Mar;65(3):361-7. doi: 10.1111/j.1600-0897.2010.00923.x. Epub 2010 Nov 19. Review.

Supplemental Content

Support Center